Engineering of Escherichia coli for targeted delivery of transgenes to HER2/neu-positive tumor cells

Biotechnology and Bioengineering

Volumn 108, Issue 7, 2011, Pages 1662-1672

  Chang, Chih Hsiang ^a   Cheng, Wei Jou ^a   Chen, Shan Yu ^b   Kao, Ming Ching ^c   Chiang, Chung Jen ^c   Chao, Yun Peng ^a  

^a FENG CHIA UNIVERSITY   (Taiwan)

^b YUAN ZE UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Affibody; Bacterial carrier; Bactofection; HER2 neu; Targeted delivery

Indexed keywords

AFFIBODY; BACTERIAL CARRIER; BACTOFECTION; HER2/NEU; TARGETED DELIVERY;

ANTIGEN-ANTIBODY REACTIONS; BACTERIA; BACTERIOLOGY; ESCHERICHIA COLI; GENE THERAPY; GENE TRANSFER; TUMORS;

CELLS;

AFFIBODY; BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GREEN FLUORESCENT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIOLYSIS; BACTERIOPHAGE PHI X 174; CANCER CELL CULTURE; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI BL21; GENE DELIVERY SYSTEM; GENE TARGETING; HUMAN; HUMAN CELL; INTERNALIZATION; NONHUMAN; TRANSGENE;

ANTIBODIES; CELL ADHESION; CELL LINE, TUMOR; ESCHERICHIA COLI; GENE TRANSFER TECHNIQUES; GENE TRANSFER, HORIZONTAL; HUMANS; PROTEIN BINDING; RECEPTOR, ERBB-2; TRANSGENES;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; EUKARYOTA;

EID: 79956102597     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.23095     Document Type: Article

References (38)

1. Alexis F, Basto P, Levy-Nissenbaum E, Radovic-Moreno F, Zhang L, Pridgen E, Wang AZ, Marein SL, Westerhof K, Molnar LK, Farokhzad OC. 2008. HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy. ChemMedChem 3: 1839-1843.
2. Al-Mariri A, Tibor A, Lestrate P, Mertens P, De Bolle X, Letesson J. 2002. Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin of P39 antigen. Infect Immun 70: 1915-1923.
3. Canine BF, Wang Y, Hatefi A. 2009. Biosynthesis and charcterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells. J Control Release 138: 188-196.
4. Casali N, Konieczny M, Schmidt MA, Riley LW. 2002. Invasion activity of a mycobacterium tuberculosis peptide presented by the Escherichia coli AIDA autotransporter. Infect Immun 70: 6846-6852.
5. Chen ZY, He CY, Ehrhardt A, Kay MA. 2003. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther 8: 495-500.
6. Chiang CJ, Chen PT, Chao YP. 2008a. Replicon-free and markerless methods for genomic insertion of DNAs in phage attachment sites and controlled expression of chromosomal genes in Escherichia coli. Biotechnol Bioeng 101: 985-995.
7. Chiang CJ, Chern JT, Wang JY, Chao YP. 2008b. Facile immoblization of evolved Agrobacterium radiobacter carbamoylase with high thermal and oxidative stability. J Agric Food Chem 56: 6348-6354.
8. Christopher AL, Penelope EL, Dixon NE. 1996. Stable high-copy-number bacteriophage λ promoter vectors for overproduction of proteins in Escherichia coli. Gene 176: 49-53.
9. Citri A, Yarden Y. 2006. EGF-ERBB signalling: Towards the systems level. Nat Rev Mol Cell Biol 7: 505-516.
10. Cossart P, Vicente MF, Mengaud J, Baquero F, Perez-Diaz JC, Berche P. 1989. Listeriolysin O is essential for virulence of Listeria Monocytogenes: Direct evidence obtained by gene complementation. Infect Immun 57: 3629-3636.
11. Critchley RJ, Jezzard S, Radford KJ, Goussard S, Lemoine NR, Grillot-Courvalin C. 2004. Potential therapeutic application of recombinant invasive E. coli. Gene Ther 11: 1224-1233.
12. Ekerljung L, Lindborg M, Gedda L, Frejd FY, Carlsson J, Lennartsson J. 2008. Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line. Biochem Biophys Res Commun 377: 489-494.
13. Fajac I, Grosse S, Collombet JM, Thevenot G, Goussard S, Danel C, Grillot-Courvalin C. 2004. Recombinant Escherichia coli as a gene delivery vector into airway epithelial cells. J Control Release 97: 371-381.
14. Giri DK, Ali-Seyed M, Li LY, Lee DF, Ling P, Bartholomeusz G, Wang SC, Hung MC. 2005. Endosomal transport of ErbB-2: Mechanism for nuclear entry of the cell surface receptor. Mol Cell Biol 25: 11005-11018.
15. Grillot-Courvalin C, Goussard S, Huetz F, Ojcius DM, Courvalin P. 1998. Functional gene transfer from intracellular bacteria to mammalian cells. Nat Biotechnol 16: 862-866.
16. BAD promoter. J Bacteriol 177: 4121-4130.
17. Hung MC, Lau YK. 1999. Basic science of HER2/neu: A review. Semin Oncol 26: 51-59.
18. Innocentin S, Guimarães V, Miyoshi A, Azevedo V, Langella P, Chatel JM, Lefèvre F. 2009. Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells. Appl Environ Microbiol 75: 4870-4878.
19. R system. J Biotechnol 116: 11-20.
20. Lee SY, Choi JH, Xu Z. 2003. Microbial cell-surface display. Trends Biotechnol 21: 45-52.
21. Li X, Stuckert P, Bosch I, Marks JD, Marasco WA. 2001. Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells. Cancer Gene Ther 8: 555-565.
22. Maurer J, Jose J, Meyer TF. 1997. Autodisplay: One-component system for efficient surface display and release of soluble recombinant proteins from Escherichia coli. J Bacteriol 179: 794-804.
23. Miller JH. 1972. Experiments in molecular genetics. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory.
24. Orlova A, Magnusson M, Eriksson TLJ, Nilsson M, Larsson B, Hoiden-Guthenberg I, Widstrom C, Carlsson J, Tolmachev V, Stahl S, Nilsson FY. 2006. Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res 66: 4339-4348.
25. Palffy R, Gardlik R, Hodosy J, Behuliak M, Resko P, Radvansky J, Celec P. 2006. Bacteria in gene therapy: Bactofection versus alternative gene therapy. Gene Ther 13: 101-105.
26. Paukner S, Stiedl T, Kudela P, Bizik J, Laham FA, Lubitz W. 2006. Bacterial ghosts as a novel advanced targeting system for drug and DNA delivery. Expert Opin Drug Deliv 3: 11-22.
27. Pawelek JM, Low KB, Bermudes D. 2003. Bacteria as tumor-targeting vectors. Lancet Oncol 4: 548-556.
28. Pilgrim S, Stritzker J, Schoen C, Kolb-Maurer A, Geginat G, Loessner MJ, Gentschev I, Goebel W. 2003. Bactofection of mammalian cells by Listeria monocytogenes: Improvement and mechanism of DNA delivery. Gene Ther 10: 2036-2045.
29. Puri A, Kramer-Marek G, Campbell-Massa R, Yavlovich A, Tele SC, Lee SB, Clogston JD, Patri AK, Blumenthal R, Capala J. 2008. HER2-specific affibody-conjugated thermosensitive liposomes (affisomes) for improved delivery of anticancer agents. J Liposome Res 18: 293-307.
30. 4 on the surface of Salmonella enterica using the autotransporter MisL. Infect Immun 70: 3611-3620.
31. Schier R, McCall A, Adams GP, Marshall KW, Merritt H, Yim M, Crawford RS, Weiner LM, Marks C, Marks JD. 1996. Isolation of picomolar affinity anti-c-erbB2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. J Mol Biol 263: 551-567.
32. Sizemore DR, Branstrom AA, Sadoff JC. 1995. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science 270: 299-302.
33. Vassaux G, Nitcheu J, Jezzard S, Lemoine NR. 2006. Bacterial gene therapy strategies. J Pathol 208: 290-298.
34. Vaysse L, Gregory LG, Harbottle RP, Perouzel E, Tolmachov O, Coutelle C. 2006. Nuclear-targeted minicircle to enhance gene transfer with non-viral vectors in vitro and in vivo. J Gene Med 8: 754-763.
35. Wang JY, Chao YP. 2006. Immoblization of cells with surface-displayed chitin-binding domain. Appl Environ Microbiol 72: 927-931.
36. Yew NS, Zhao H, Przybylska M, Wu IH, Tousignant JD, Scheule RK, Cheng SH. 2002. CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo. Mol Ther 5: 731-738.
37. Yu YA, Shabahang S, Timiryasova TM, Zhang Q, Beltz R, Gentschev I, Goebel W, Szalay AA. 2004. Visualization of tumors metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 22: 313-320.
38. Zhao M, Yang M, Li XM, Jiang P, Baranov E, Li S, Xu M, Penman S, Hoffman RM. 2005. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci USA 102: 755-760.